FES antibody (AA 644-663)

Catalog No. ABIN2620790

This Rabbit Polyclonal antibody specifically detects FES in WB. It exhibits reactivity toward Human, Mouse, Rat, Monkey, Chimpanzee and Orang-Utan.

Quick Overview for FES antibody (AA 644-663) (ABIN2620790)

Target: FES (Feline Sarcoma Oncogene (FES))

Reactivity: Human, Mouse, Rat, Monkey, Chimpanzee, Orang-Utan

Host: Rabbit

Clonality: Polyclonal

Conjugate: This FES antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-FES Antibody

Binding Specificity: AA 644-663

Specificity: Widely expressed. Detected in adult colon epithelium.

Purification: Immunogen affinity purified

Immunogen: A synthetic peptide corresponding to a sequence at the C-terminus of human FES(644-663aa FLTFLRTEGARLRVKTLLQM), identical to the related mouse and rat sequences.

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Reconstitution: Distilled water

Concentration: Lot specific

Buffer: Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.

Preservative: Sodium azide, Thimerosal (Merthiolate)

Precaution of Use: This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.

Handling Advice: Avoid freeze-thaw cycles.

Storage: 4 °C,-20 °C

Storage Comment: At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.

Target Details for FES

Target: FES (Feline Sarcoma Oncogene (FES))

Alternative Name: FES

Background: Name/Gene ID: FES
Subfamily: Fes (Fps)
Family: Protein Kinase

Synonyms: FES, c-fes, FPS, Feline sarcoma oncogene, Proto-oncogene c-Fps, v-fps, p93c-fes, Proto-oncogene c-Fes, v-fes, v-fes feline sarcoma viral

Gene ID: 2242

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Signaling Events mediated by VEGFR1 and VEGFR2